Iomeron (Iomeprol)

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When injected into the bloodstream, a joint space, or the cerebrospinal fluid, the iodine distributes to the area of interest and attenuates the X‑ray beam, producing a higher contrast between the enhanced structures and surrounding tissues on the resulting image.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function and the required level of contrast enhancement. The healthcare professional selects the appropriate volume and concentration for each procedure; patients should not adjust the dose without medical guidance.

The safety of Iomeron in pregnancy and lactation has not been definitively established. Because iodinated contrast agents cross the placenta and may be secreted in breast milk, they should be used only if the diagnostic benefit outweighs potential risks, and only under the direction of a qualified clinician.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Iomeron (Iomeprol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse reactions, making it a preferred choice for many diagnostic imaging procedures.

Iomeron should be stored at or below 25 °C in its original packaging, protected from light, moisture and freezing. The container must be kept sealed until use, and any unused solution should be discarded according to local regulations. Handling should be performed by trained personnel using aseptic technique.

Iomeron is supplied as an injectable solution and is administered intravenously for angiography, intra‑articularly for arthrography, or intrathecally for myelography. The injection is performed by qualified healthcare professionals using appropriate aseptic techniques and dosage calculations tailored to the specific imaging study.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and rare events like seizures, hypotension or cardiac arrhythmias. Patients with known iodine allergy, impaired renal function or uncontrolled thyroid disease should be closely monitored or may require alternative imaging strategies.

Iomeron is contraindicated in patients with a documented hypersensitivity to iodinated contrast media, those with severe renal impairment where alternative imaging is feasible, and individuals with uncontrolled hyperthyroidism. Caution is also advised for patients on metformin with reduced kidney function, and the decision to use the agent should be made by the treating physician.